drugset / Trial / NCT05369819

Effect of Midazolam Premedication on Opioid-induced Mask Ventilation Difficulty

NCT05369819

Phase 4 Completed 120 enrolled Karaman Training and Research Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

Mask ventilation has great importance during anesthesia induction because it is the only way to oxygenate patients who have lost consciousness and spontaneous breathing. Opioid-derived drugs used in anesthesia induction may cause difficulty in mask ventilation due to their chest wall rigidity and respiratory depressant effects. Adequate muscle relaxation and depth of anesthesia may assist with mask ventilation. It is known that premedication reduces anxiety and has a relaxing effect on airway muscles. Midazolam is frequently used in premedication because it has a rapid onset of action and does not cause hemodynamic changes. In addition, midazolam may relax the airway by acting directly on the airway smooth muscle and thus facilitate mask ventilation during anesthesia induction. In this study, the investigators will evaluate the effect of midazolam premedication on the mask ventilation after induction with remifentanil.

Timeline

Start
2022-05-24
Primary completion
2024-01-02
Completion
2024-01-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Midazolam Small molecule 0.035 mg/kg Intravenous

Indications

No indication recorded.